Promising prostate device trial halted after just one patient

NCT ID NCT05884580

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new device that uses water electrolysis to shrink prostate tissue and relieve urinary symptoms in men with benign prostatic hyperplasia (BPH). The goal was to see if it could improve symptoms by at least 30% and be safe. However, the trial was terminated early after enrolling only one participant, so no meaningful conclusions can be drawn.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Neuflo BPH Treatment System (a device that uses water electrolysis to reduce prostate tissue)
What this could lead to
If it worked, this device could offer a minimally invasive, outpatient option to relieve urinary symptoms from an enlarged prostate.
What could go wrong
The trial was terminated after enrolling only 1 person, so we have very little data on safety or effectiveness. It is unclear if the device works or is safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Lower Urinary Tract Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Urology Bay of Plenty

    Tauranga, Tauranga, 3112, New Zealand

More trials for these conditions

Other studies related to the condition(s) this trial covers.